Perfil
Mr. Ashley A. Woodcock is a Chairman at Axalbion SA and a Chairman at Axalbion Therapeutics Ltd. He is on the Board of Directors at North West Lung Centre.
Mr. Woodcock was previously employed as a Non-Executive Chairman by Reacta Biotech Ltd.
Cargos activos de Ashley Arthur Woodcock
| Empresas | Cargo | Inicio |
|---|---|---|
North West Lung Centre
North West Lung Centre Medical/Nursing ServicesHealth Services Provides Other human health activities services | Director/Miembro de la Junta | - |
Axalbion SA | Presidente | - |
Axalbion Therapeutics Ltd.
Axalbion Therapeutics Ltd. BiotechnologyHealth Technology Operates as a clinical-stage pharmaceutical company that developing TRPM8 agonists for the treatment of chronic cough and dry eyes | Presidente | - |
Antiguos cargos conocidos de Ashley Arthur Woodcock.
| Empresas | Cargo | Fin |
|---|---|---|
Reacta Biotech Ltd.
Reacta Biotech Ltd. Miscellaneous Commercial ServicesCommercial Services Develops, manufactures and supplies oral food materials and technologies to pharmaceuticals | Fundador | 19/02/2026 |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 4 |
|---|---|
Reacta Biotech Ltd.
Reacta Biotech Ltd. Miscellaneous Commercial ServicesCommercial Services Develops, manufactures and supplies oral food materials and technologies to pharmaceuticals | Commercial Services |
North West Lung Centre
North West Lung Centre Medical/Nursing ServicesHealth Services Provides Other human health activities services | Health Services |
Axalbion SA | |
Axalbion Therapeutics Ltd.
Axalbion Therapeutics Ltd. BiotechnologyHealth Technology Operates as a clinical-stage pharmaceutical company that developing TRPM8 agonists for the treatment of chronic cough and dry eyes | Health Technology |
- Bolsa de valores
- Insiders
- Ashley Arthur Woodcock
















